Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra

NeuroReport

Volumn 8, Issue 3, 1997, Pages 649-652

  French, Edward D ^a   Dillon, Kathryn ^a   Wu, Xiaofang ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

cannabinoids; electrophysiology; marijuana; substantia nigra; ventral tegmental area

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID; TETRAHYDROCANNABINOL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ELECTROPHYSIOLOGY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NERVE CELL EXCITABILITY; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

EID: 0030887785     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199702100-00014     Document Type: Article

References (23)

1. Wise RA. Pharmacol Ther 35, 227-263 (1987).
2. Koob GF. Trends Pharmacol Sci 13, 177-184 (1992).
3. Ton JMNC, Gerhardt GA, Friedemann M et al. Brain Res 451, 59-68 (1988).
4. Gardner EL and Lowinson JH. Pharmacol Biochem Behav 40, 571-580 (1991).
5. Souilhac J, Poncelet M, Rinaldi-Carmona M et al. Pharmacol Biochem Behav 51, 3-7 (1995).
6. Sakurai-Yamashita Y, Ohta H, Shimazoe T et al. Life Sci 37, 2181-2185 (1985).
7. French ED, Mura A and Wang T. Synapse 13, 108-116 (1993).
8. Chen J, Paredes W, Lowinson J et al. Neurosci Lett 129, 136-140 (1991).
9. Gonon FG and Buda MJ. Neuroscience 14, 765-774 (1985).
10. Bowere MB Jr and Morton JB. Prog Neuro-Psychopharmacol Biol Psychiatry 18, 961-964 (1994).
11. Seigenbaum JJ, Bergmann F, Richmond SA et al. Proc Natl Acad Sci USA 86, 9584-9587 (1989).
12. Wang T and French ED. Synapse 13, 270-277 (1993).
13. Herkenham M, Lynn AB, de Costa BR et al. Brain Res 547, 267-274 (1991).
14. Chen J, Marmur R, Pulles A et al. Brain Res 621, 65-70 (1993).
15. Herkenham M, Lynn AB, Johnson MR et al. J Neurosci 11, 563-583 (1991).
16. Matsuda LA, Bonner TI and Lolait SJ. J Comp Neurol 327, 535-550 (1993).
17. Margulies JE and Hammer RP Jr. Eur J Pharmacol 202, 373-378 (1991).
18. Bowers MB Jr and Hoffman FJ Jr. Brain Res 366, 405-407 (1986).
19. Prescott WR, Gold LH and Martin BR. Psychopharmacology 107, 117-124 (1992).
20. Kelivas PW. Brain Res Rev 18, 75-113 (1993).
21. D'Ambra TE, Estep KG, Bell MR et al. ??
22. Compton DR, Gold LH, Ward SJ et al. J Pharmacol Exp Ther 293, 1118-1126 (1992).
23. Mirenowicz J and Schultz W. Nature 379, 449-451 (1996).